We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Greiner Bio-One Launches Tube Holder for Blood Collection

By LabMedica International staff writers
Posted on 18 Dec 2018
Greiner Bio One International (Kremsmünster, Oberösterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. More...
The tube offers simple handling and can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae.

Greiner Bio-One develops collection systems for human and veterinary samples that make the flow of daily routine tasks in hospitals, laboratories or doctors' surgeries simpler and safer. The company offers sample collection products made out of plastic and also provides custom-made solutions. Greiner Bio-One’s VACUETTE product line is used in hospitals, laboratories, doctors’ offices and blood donor centers in more than 100 countries across the world.

The company has now added VACUETTE SAFELINK tube holder to its product line that comes with a luer lock feature, setting it apart from the conventional Greiner Bio-One tube holders and making it particularly suitable for blood collection from venous access devices according to guideline recommendations (Infusion Therapy Standard of Practice, Revised 2016).

Furthermore, VACUETTE SAFELINK, which is manufactured from unbreakable plastic and does not contain natural rubber latex, offers a secure screw connection between the holder and collection product to ensure safe and successful blood collection. With a controlled threading movement, the single-use product connects safely and smoothly to the respective medical device. Tests have shown that the secure connection can withstand pressures of up to 185mmHg, which combined with its functional design and practical handling, could contribute significantly to increased efficiency in everyday healthcare situations.


New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.